Ednan Sheikh, MD
Pain Medicine · Clifton, NJNPI 1013128016
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.0%. Reporting peaked in 2021 at $2,690 and has fallen 82.0% since, to $484 in 2025.
Across 253 payments — averaging $30.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Medtronic$1K
- Surgentec$1K
- Redhill Biopharma Inc.$1K
- Boston Scientific$1K
- Collegium Pharmaceutical, Inc.$587
- plus $936 from 22 others
What the payments were for
- Consulting fees$1,04013%
- Travel & lodging$2,93037%
- Food & beverage$3,85949%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 106 | $1,410 |
| Medtronic(2 entities) | 11 | $1,338 |
| Surgentec | 1 | $1,307 |
| Redhill Biopharma Inc. | 10 | $1,160 |
| Boston Scientific | 10 | $1,090 |
| Collegium Pharmaceutical, Inc. | 54 | $587 |
| Biodelivery Sciences International, Inc. | 14 | $160 |
| AbbVie(2 entities) | 9 | $130 |
| Si-bone, Inc. | 4 | $112 |
| AstraZeneca | 6 | $83 |
| Shionogi Inc | 5 | $68 |
| Nalu Medical, Inc. | 1 | $42 |
| GSK | 3 | $40 |
| Relievant Medsystems, Inc. | 2 | $39 |
| Galderma Laboratories, L.p. | 2 | $32 |
| Azurity Pharmaceuticals, Inc. | 2 | $32 |
| Protega Pharmaceutials Inc | 2 | $29 |
| Abbott | 1 | $22 |
| Foundation Fusion Solutions, LLC | 1 | $19 |
| Vertex | 1 | $18 |
| Valinor Pharma, LLC | 1 | $17 |
| Biotronik NRO, Inc. | 1 | $16 |
| Electronic Waveform Lab, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| IBSA Pharma Inc. | 1 | $13 |
| Biocompatibles, Inc. | 1 | $13 |
| Almatica Pharma LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- 3D GraftRasp System$1,307
- MOVANTIK$1,040
- ClosureFast$910
- Intracept$828
- SPECTRA WAVEWRITER$108
How this compares
$7,829 in reported general payments places this provider in the 85th percentile of 256 pain medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 85 | $206,072 |
| Xtampza ErOxycodone Myristate | 25 | $13,037 |
| OxycontinOxycodone Hcl | 17 | $10,751 |
| MovantikNaloxegol Oxalate | 16 | $6,466 |
| Diclofenac Sodium | 33 | $6,159 |
| Lidocaine | 59 | $5,851 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 96 | $2,367 |
| Oxycodone Hcl | 57 | $1,098 |
| Gabapentin | 102 | $708 |
| EndocetOxycodone Hcl/Acetaminophen | 20 | $634 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $598 |
| Cyclobenzaprine Hcl | 84 | $577 |
| Tramadol Hcl | 39 | $219 |
| Ibuprofen | 25 | $164 |
| Meloxicam | 54 | $132 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,410 | $206,07285 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $587 | $13,03725 claims |
| Redhill Biopharma Inc.Movantik | $1,160 | $6,46616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 256 pain medicine providers in New Jersey.
Other pain medicine in Clifton
- Dipan PatelClifton$50K
- Neil SinhaClifton$9K
- Sean LiShrewsbury$1.2M
- Matthias WiederholzLawrenceville$853K
- Todd StitikNewark$370K
- Peter StaatsShrewsbury$286K
- Warren GraceEdison$158K
- Caitlin InnerfieldHaddonfield$97K
- Anson MoiseEnglewood$78K
- Pavli DemianSomerset$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.